Literature DB >> 8447714

Adenine phosphoribosyltransferase deficiency with renal deposition of 2,8-dihydroxyadenine leading to nephrolithiasis and chronic renal failure.

K H Fye1, A Sahota, D C Hancock, A B Gelb, J Chen, J W Sparks, R K Sibley, J A Tischfield.   

Abstract

Homozygous adenine phosphoribosyltransferase deficiency is a genetic defect that is associated with 2,8-dihydroxyadenine urolithiasis. Since the prevalence of the heterozygous state is found in 0.4% to 1.2% of the population, it is surprising that more cases of 2,8-dihydroxyadenine urolithiasis have not been reported. Herein we describe a patient with complete adenine phosphoribosyltransferase deficiency with 2,8-dihydroxyadenine urolithiasis leading to chronic renal failure. Gene sequencing revealed that the patient is a compound heterozygote. One of the mutations (a T insertion between bases 346 and 347) has been encountered before, but the second (a G-to-A substitution at base 1356) has not been previously reported. Possible explanations for the unexpected rarity of 2,8-dihydroxyadenine urolithiasis are discussed.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8447714

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  8 in total

1.  Phenotype and genotype characterization of adenine phosphoribosyltransferase deficiency.

Authors:  Guillaume Bollée; Cécile Dollinger; Lucile Boutaud; Delphine Guillemot; Albert Bensman; Jérôme Harambat; Patrice Deteix; Michel Daudon; Bertrand Knebelmann; Irène Ceballos-Picot
Journal:  J Am Soc Nephrol       Date:  2010-02-11       Impact factor: 10.121

2.  Radiopaque 2,8-dihydroxyadenine lithiasis.

Authors:  T Yagisawa; Y Yamazaki; H Toma; N Kamatani
Journal:  Int Urol Nephrol       Date:  1999       Impact factor: 2.370

3.  Adenine phosphoribosyltransferase-deficient mice develop 2,8-dihydroxyadenine nephrolithiasis.

Authors:  S J Engle; M G Stockelman; J Chen; G Boivin; M N Yum; P M Davies; M Y Ying; A Sahota; H A Simmonds; P J Stambrook; J A Tischfield
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-28       Impact factor: 11.205

4.  APRT from erythrocytes of HGPRT deficient patients: kinetic, regulatory and thermostability properties.

Authors:  Javier Crespillo; Pilar Llorente; Luisa Argomániz; Celia Montero
Journal:  Mol Cell Biochem       Date:  2003-12       Impact factor: 3.396

5.  Urinary L-type fatty acid-binding protein can reflect renal tubulointerstitial injury.

Authors:  Tamami Tanaka; Kent Doi; Rui Maeda-Mamiya; Kousuke Negishi; Didier Portilla; Takeshi Sugaya; Toshiro Fujita; Eisei Noiri
Journal:  Am J Pathol       Date:  2009-03-05       Impact factor: 4.307

6.  Is adenine phophorybosiltransferase deficiency a still underdiagnosed cause of urolithiasis and chronic renal failure? A report of two cases in a family with an uncommon novel mutation.

Authors:  Italia Perruzza; Valentina Di Pietro; Barbara Tavazzi; Giuseppe Lazzarino; Marco Gamberini; Paola Barsotti; Angela Maria Amorini; Bruno Giardina; Alessandro Balducci
Journal:  NDT Plus       Date:  2008-06-19

7.  Sclerostin Protects Against Vascular Calcification Development in Mice.

Authors:  Annelies De Maré; Britt Opdebeeck; Ellen Neven; Patrick C D'Haese; Anja Verhulst
Journal:  J Bone Miner Res       Date:  2022-02-15       Impact factor: 6.390

Review 8.  Recurrence of crystalline nephropathy after kidney transplantation in APRT deficiency and primary hyperoxaluria.

Authors:  Guillaume Bollée; Pierre Cochat; Michel Daudon
Journal:  Can J Kidney Health Dis       Date:  2015-09-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.